Both in Pharmaceuticals
CryoPort vs Aktis Oncology
Over the past year CYRX returned +55.8% and AKTS returned −33.3%; their daily moves had a correlation of 0.25.
CYRX +55.8% AKTS −33.3%Growth of $1, one year, split-adjusted
| Metric | CYRX | AKTS |
|---|---|---|
| Price | $16.45 | $14.94 |
| Market cap | $833.2M | $831.0M |
| Today | +1.36% | +2.40% |
| 1 month | −9.3% | −19.3% |
| 6 months | +34.9% | −23.1% |
| Year to date | +71.4% | — |
| 1 year | +78.0% | — |
| Revenue growth (YoY) | +7.7% | — |
| Gross margin | 46.6% | 100.0% |
| Net margin | −20.9% | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | 4.5× | — |
| Net cash | $208.7M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 40.2% | 55.5% |
| Short % of float | 5.3% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).